REVENUES: | |
Net product revenues | 278.26M |
Collaborative agreement revenues | 1K |
Royalty and license revenues | 1.63M |
Total revenues | 279.9M |
OPERATING EXPENSES: | |
Cost of sales (excludes amortization of developed product technology) | 50.74M |
Research and development | 160.83M |
Selling, general and administrative | 118.76M |
Intangible asset amortization and contingent consideration | 9.65M |
Total operating expenses | 339.98M |
INCOME FROM OPERATIONS | -60.09M |
Equity in the loss of BioMarin/Genzyme LLC | -104K |
Interest income | 1.63M |
Interest expense | -9.98M |
Net gain from sale of investments | |
INCOME BEFORE INCOME TAXES | |
Provision for income taxes | -24.02M |
NET INCOME (LOSS) | -42.8M |
NET INCOME (LOSS) PER SHARE, BASIC | -0.26 |
NET INCOME (LOSS) PER SHARE, DILUTED | -0.26 |
Weighted average common shares outstanding, basic | 167.71M |
Weighted average common shares outstanding, diluted | 167.71M |